Understanding the mechanisms of frontotemporal lobar degeneration with TDP-43 involvement

Genomics Core

NIH-funded research Stanford University · NIH-10915042

This study is looking into how a protein called TDP-43 might cause frontotemporal lobar degeneration (FTLD), and it's for anyone interested in understanding this condition better, as it could lead to new insights and treatments for patients.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-10915042 on NIH RePORTER

What this research studies

This research focuses on unraveling the mechanisms behind frontotemporal lobar degeneration (FTLD) associated with TDP-43, a protein linked to neurodegenerative diseases. A diverse team of experts in genetics, neuroscience, and pathology will investigate how mis-splicing events caused by TDP-43 dysfunction may initiate the disease process. The project aims to integrate human genetics from the outset and will provide access to high-resolution brain images and data through a web portal, enabling the research community to explore new hypotheses about FTLD. Patients may benefit from advancements in understanding and potential treatments for FTLD-TDP.

Who could benefit from this research

Good fit: Ideal candidates for participation are individuals diagnosed with frontotemporal lobar degeneration or related neurodegenerative conditions.

Not a fit: Patients with other forms of dementia not related to frontotemporal lobar degeneration may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with frontotemporal lobar degeneration.

How similar studies have performed: Previous research has shown promise in understanding TDP-43's role in neurodegeneration, indicating that this approach could yield significant insights.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.